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Abstract 
Novel clearing techniques have revolutionized three-dimensional confocal 
imaging of the brain without the need for physical tissue sectioning. We 
evaluated three clearing methods, ScaleA2, ClearT2, and 3DISCO for visualizing 
native and tissue engineered muscle by confocal microscopy. We found that 
Clear
T2
 treatment improved the depth of visualization of immunohistochemical 
staining slightly, but did not improve depth of visualization of endogenous green 
fluorescent protein (GFP). ScaleA2 preserved endogenous GFP signal better and 
permitted significantly deeper GFP imaging, but it was incompatible with 
tropomyosin immunohistochemical staining. 3DISCO treatment preserved both 
endogenous GFP and immunohistochemical staining, and permitted significantly 
deeper imaging. Clearing time for the 3DISCO procedure is short compared to 
ScaleA2 and ClearT2. We suggest that 3DISCO is the preferable clearing method for 
native and tissue engineered skeletal muscle tissue. 
 
Key words: bio-artificial, clearing, confocal microscopy, skeletal muscle, tissue 
engineering, visualization 
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Three-dimensional (3D) visualization of tissue is important for studying the 
morphology and distribution of cells. Confocal microscopy enables optical 
sectioning of tissues up to 150 µm deep (Miyawaki 2013, Hama et al. 2011). Great 
progress in 3D imaging has been made during the past decade; images can be 
obtained deeper in a tissue with increased resolution. Two-photon microscopy 
enables deeper light penetration and less phototoxicity, because light with a 
longer wavelength is used, which permits visualization to a depth of 500–800 µm 
(Miyawaki 2013, Hama et al. 2011). Increased optical path lengths in the sample, 
however, increases light scattering and limits resolution. 
Light sheet microscopy, which differs from conventional wide field and 
confocal fluorescence microscopy by illumination perpendicular to the direction 
of observation, has been applied to biology recently to visualize partially 
transparent samples such as fish embryos (Huisken et al. 2004). Most biological 
tissues, however, are relatively opaque, which prevents high resolution imaging of 
thick specimens. Moreover, the different compositions of the cell membrane 
(lipid) and intra- and extracellular fluids create a refractive index interface that 
scatters light. Consequently, methods have been developed to clear biological 
samples. Optical light scattering can be reduced by optical clearing, which renders 
tissue specimens transparent, to achieve refractive uniformity throughout the 
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specimen. Optical clearing is achieved by incubating the fixed sample with a 
clearing agent. Dehydration of the sample is required before clearing with 
hydrophobic clearing agents. The clearing agent, which has a high refractive index 
similar to the refractive index of lipids, is used to replace the aqueous intra- and 
extracellular fluids. This reduces light scattering between the cell membrane 
(lipid) and the intra- and extracellular fluid and renders the tissue more 
transparent (Sakhalkar et al. 2007). 
Although tissue clearing techniques were pioneered a century ago 
(Spalteholz 1914), their use has become widely appreciated only recently. 
Clearing first became critical for modern imaging methods for optical projection 
tomography, which enabled visualization of whole mouse embryos (Sharpe et al. 
2002). These investigators used a 2:1 mixture of benzylbenzoate:benzyl alcohol 
(BABB) following dehydration with ethanol and hexane. This protocol is not fully 
compatible with fluorescence, however, and other clearing agents were 
developed to preserve better the fluorescent signals from labeled cells. 
New tissue clearing techniques have been used mainly for embryological 
and neural research (Becker et al. 2012, Chung et al. 2013, Hama et al. 2011, 
Kuwajima et al. 2013, Sakhalkar et al. 2007). The efficacy of these agents for adult 
muscle or tissue engineered muscle, however, has not been demonstrated. 
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Tissues possess different extracellular matrix (ECM) compositions, 
microvasculature and cell types, all of which produce different light scattering 
effects. These structures affect the extent to which the tissue is rendered 
transparent by clearing. 
We evaluated the efficacy of three recently described clearing methods: 
ScaleA2 (Hama et al. 2011), ClearT2 (Kuwajima et al. 2013) and 3DISCO (Ertürk et 
al. 2012). These methods were used originally for imaging mouse brains and 
ostensibly maintained fluorescence. We evaluated depth of visualization by 
confocal imaging in green fluorescent protein (GFP)-expressing mouse skeletal 
muscle before and after clearing. We then assessed the suitability of these 
clearing techniques for visualizing myofiber organization and endothelial cell 
network formation in tissue engineered bio-artificial muscle (BAM) constructs. 
BAMs can be created in vitro by culturing and differentiation of adult 
myogenic progenitor cells in hydrogels, such as fibrin or collagen (Thorrez et al. 
2006, Vandenburgh et al. 2008). BAMs are composed of aligned multinucleated 
myofibers, which generate tension and can be stimulated electrically to generate 
active force (Powell et al. 2002, Vandenburgh et al. 2008). The BAM system is a 
well-defined model for studying in vitro differentiation of myogenic progenitor 
cells, myofiber formation and the effect of drugs on muscle force generation 
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(Vandenburgh et al. 2008). BAMs enable characterization of myofiber properties 
including alignment, shape and fusion index, as well as behavior, e.g., cellular 
distribution and differentiation of other cell types in co-culture. Unlike muscle in 
vivo, current state-of-the-art BAMs lack innervation, fat tissue, organized 
connective tissue and vascularization. 
To study vasculogenesis using the BAM model, we traced the distribution 
and organization of GFP-labeled human umbilical vein endothelial cells (HUVECs), 
co-cultured in 3D, throughout the BAM. Light scattering and refraction, however, 
limited the depth of visualization, which prevented 3D imaging of the entire BAM. 
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Material and methods  
All animal experiments were carried out in compliance with the Ethical Guidelines 
of KU Leuven. 
 
Cell culture 
HUVECs that constitutively express GFP (Angio-proteomie, Boston, MA) were 
cultured in T25 culture flasks coated with gelatin (Millipore, Billerica, MA) in 
endothelial growth medium (EGM-2 using a bullet kit, composed of basal medium 
and supplements, Lonza, Basel, Switzerland). GFP-HUVECs were divided at 90% 
confluence and used for our experiment at passage 7. Human myoblasts isolated 
from a healthy 52-year-old male (gift from Dr. H. Vandenburgh) were cultured in 
skeletal muscle growth medium (SkGM; Lonza) supplemented with 15% fetal 
bovine serum (FBS; Life Technologies, Carlsbad, CA). Myoblasts were divided at 
60−70% confluence and used in experiments at about 20 doublings.  
 
Tissue engineering 
BAMs were constructed in custom molds with a total casting volume of 1 ml. One 
million cells were mixed with either fibrin or collagen based hydrogels. Cells used 
in the BAMs were a mixture of 7 x 10
5
 human myoblasts and 3 x 10
5 
GFP-HUVECs. 
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For fibrin BAMs, cells were mixed in a fibrin hydrogel (1 mg/ml) and for collagen 
BAMs the hydrogel was composed of 1 mg/ml rat tail collagen with 13% matrigel 
(BD Biosciences, San Jose, CA) as described earlier (Thorrez et al. 2008). The 
constructs were kept in culture for 7 days in EGM-2 medium to allow myoblast 
fusion and differentiation to myofibers, and endothelial network formation. 
 
Whole mount fluorescent staining and confocal microscopy 
BAMs were washed three times in phosphate-buffered saline (PBS; Invitrogen, 
Carlsbad, CA), then removed from the molds. They then were fixed in 4% 
formaldehyde (Merck, Darmstadt, Germany) for 1 h and stored at 4° C in PBS. 
Samples were fixed a second time in methanol at -20° C for 20 min, then washed 
three times in PBS for 15 min each time. Samples were permeabilized and 
nonspecific binding was blocked by incubation at room temperature for 1 h in 
blocking buffer containing 1% bovine serum albumin (BSA) (Sigma-Aldrich, St. 
Louis, MO) and 0.2% Triton-X-100 (Sigma-Aldrich) in PBS. Subsequently, BAMs 
were incubated overnight at 4° C with a primary anti-tropomyosin antibody 
(T9283; Sigma) 1:100 in blocking buffer. BAMs then were washed three times 
with PBS for 15 min each time and incubated with a goat anti-mouse secondary 
antibody (Alexa Fluor 568; Invitrogen) for 30 min in the dark. BAMs were washed 
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three times with PBS for 15 min each time and incubated in DAPI (Invitrogen) 
(1:10000 in PBS) for 1 h. BAMs were stored in PBS in the dark, viewed by confocal 
microscopy within 48 h, then cleared. In some cases, a second fluorescence 
staining was performed after the clearing procedure as described above.  
 
Adult skeletal muscle 
Skeletal muscle (quadriceps and gastrocnemius) was obtained from the hind limbs 
of a female beta β-actin-GFP mouse model (kindly donated by Dr. P. Carmeliet). 




After fixation, mouse skeletal muscle tissue and BAMs were subjected to one of 
the following clearing agents: Clear
T2
 (Kuwajima et al. 2013), ScaleA2 (Hama et al. 
2011) or 3DISCO (Ertürk et al. 2012). 
For clearing with Clear
T2
, a 20% polyethylene glycol (PEG) solution was 
prepared by stirring powdered PEG 4000 MW (Sigma-Aldrich) in water at 37° C for 
30 min. Skeletal muscle and BAMs first were immersed for 1 h at room 
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temperature in 25% formamide (Sigma-Aldrich):10% PEG solution followed by 
incubation for 12 h in 50% formamide:20% PEG solution.  
For clearing with ScaleA2, mouse skeletal muscle tissue and BAMs were 
incubated for 2 weeks in ScaleA2 solution, which is composed of 4 M urea (Sigma-
Aldrich), 10% (w/v) glycerol (Acros, Geel, Belgium) and 0.1% (w/v) Triton-X-100 
(Sigma-Aldrich). 
For 3DISCO clearing, skeletal muscle and BAMs were treated as described 
earlier (Ertürk et al. 2012). Briefly, tissues were placed in small glass bottles and 
dehydrated with increasing concentrations of tetrahydrofuran (THF) in MilliQ 
(Millipore) filtered water. Glass vials containing 50, 70, 80 and 100% THF were 
placed on a rotating wheel in the dark. Each dehydration step was a single 
incubation for 30 min, except for the last step, which was repeated three times. 
After dehydration, clearing was performed with dibenzyl ether (DBE) for 1 h 
(Becker et al. 2012). After clearing, mouse skeletal muscle tissues and BAMs were 
imaged macroscopically (Sony DSCWX60W, Tokyo, Japan) to document changes in 
transparency, then viewed by confocal microscopy. 
 
Confocal imaging  
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Imaging was performed using an LSM710 confocal microscope (Zeiss, 
Oberkochen, Germany and Zen software (Zeiss). All images were acquired using a 
25 x objective, NA = 0.55, and working distance of 26 mm.  
 
Statistics 
Data are presented as means ± standard deviations and statistical analyses were 
performed using GraphPad Prism; n represents the number of images that were 
analyzed. One-way ANOVA was used for testing multiple groups. To examine 
tissue shrinkage or expansion, we measured tissues along the x, y and z axes and 
calculated the ratios before and after clearing, which were compared to 1 (H0 = no 
length change) by a one sample t-test. We used a confidence level of p ≤ 0.05. 
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Clearing mouse skeletal muscle  
Adult mouse skeletal muscle tissue that constitutively expressed GFP under 
control of a β-actin promoter was used to test the effect of different clearing 
agents on confocal imaging depth. Muscle tissue was fixed overnight in 4% 
formaldehyde, imaged by confocal microscopy, then subjected to clearing agents 
ScaleA2 (Hama et al. 2011), ClearT2 (Kuwajima et al. 2013) or 3DISCO (Ertürk et al. 
2012). Clearing with ScaleA2 required 2 weeks compared to 13 h with ClearT2 and 
4 h with 3DISCO. After clearing with ScaleA2, mouse skeletal muscle appeared 
slightly more transparent than uncleared fixed tissue, but Clear
T2
 treatment did 
not cause macroscopically observable improvement in tissue transparency. 
Clearing with 3DISCO resulted in remarkably transparent tissue (Fig. 1). Muscle 
treated with 3DISCO hardened the tissue, by contrast to the other clearing 
procedures. 
The GFP signal could be detected to a depth of 162.3 ± 29.5 µm (n = 30) in 
uncleared muscle tissue. Spatial resolution that permitted identification of 
separate myofibers, however, could be obtained only to a depth of 74.5 ± 22.2 
µm (n = 20) (Fig. 2). After Clear
T2
 treatment, the GFP imaging depth was 179.2 ± 
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40.2 µm (n = 18), which was not significantly different from untreated muscle 
tissue (Figs. 2, 3A). In addition, spatial resolution was slightly better than, but not 
significantly different from untreated muscle; identification of separate myofibers 
extended to a depth of 83.4 ± 25.0 µm (n = 16). 
The GFP signal in muscle tissue cleared with ScaleA2 was detected to a 
depth of 313.3 ± 41.4 µm (n = 15), which was significantly deeper than for 
untreated tissue (Figs. 2, 3A) (p < 0.001). Owing to improved transparency and 
enhanced light penetration, resolution improved significantly compared to 
untreated tissue to allow identification of separate myofibers at a maximum 
depth of 145.8 ± 56.1 µm (n = 18) (p < 0.001). 
3DISCO clearing of GFP muscle tissue enabled detection of GFP signal to a 
depth of 400.8 ± 30.6 µm (n = 18), which was significantly deeper than for 
untreated tissue (p < 0.001) (Figs. 2, 3A). Separate myofibers could be 
distinguished with adequate resolution five times deeper than in uncleared tissue 
and more than twice as deep as ScaleA2 cleared specimens (372.1 ± 46.2 µm, n = 
16). Figure 3A shows image depth quantitatively following Clear
T2
, ScaleA2 or 
3DISCO treatments versus uncleared tissue.  
We investigated possible muscle tissue shrinkage or expansion due to 
clearing and found 2.8 ± 8.6% (n = 12) and 19.9 ± 15.6% (n = 9) linear shrinkage 
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or 3DISCO treatment, respectively, and 4.4 ± 20.5 % (n = 8) linear 
expansion after ScaleA2. Only 3DISCO treatment caused significant shrinkage 
compared to untreated tissue (p < 0.01).  
 
Clearing BAM  
BAMs differ from muscle in vivo; they lack innervation and vascularization, and 
are composed of extracellular matrix that lacks organized connective tissue. 
Therefore, we also tested whether clearing agents could affect the transparency 
and depth of visualization for BAMs.  
In uncleared fibrin BAMs, GFP-HUVECs were visible to a depth of 180.8 ± 
18.37 µm (n = 20) with sufficient resolution to distinguish individual cells. In 
uncleared collagen BAMs, GFP-HUVECs were visible to a depth of 157.5 ± 18.0 µm 
(n = 10), which was not significantly different from fibrin BAMs.  
Collagen BAMs did not appear more transparent than untreated BAMs after 
clearing with either ScaleA2 (2 weeks) or ClearT2 for 13 h, but they had a 
transparent and glazed appearance after 3DISCO clearing (Fig. 4). Fibrin BAMs did 
not appear more transparent after Clear
T2 
treatment, but ScaleA2 and 3DISCO 
treatment produced obvious clearing (Fig. 4). Like native muscle tissue, 3DISCO 
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treatment hardened the BAMs, whereas ScaleA2 treatment produced softer, 
almost slimy tissue, which made the BAM structure more difficult to handle. 
 After clearing fibrin BAMs with Clear
T2
, the mean depth of visualization of 
GFP was 133.9 ± 56.7 µm (n = 14), which was significantly less than the uncleared 
BAMs (Fig. 3B). Representative images of Clear
T2
 treated BAMs are shown in Fig. 
5A. After ScaleA2 clearing of fibrin BAMs, the mean depth of visualization of the 
endogenous GFP signal of HUVECs was increased significantly to 290.0 ± 24.4 µm 
(n = 15) compared to 180.8 ± 18.4 µm (n = 20) for uncleared BAMs (p < 0.001) 
(Fig. 4). 3DISCO clearing of fibrin BAMs enabled visualization of GFP signals to a 
mean depth of 293.0 ± 34.4 µm (n = 10), which was significantly deeper than for 
uncleared BAMs (Figs. 4, 5A). In addition, 3DISCO clearing of collagen BAMs 
produced a significant increase in the mean depth of GFP signal detection to 500 
± 33.0 µm (n = 5) compared to untreated BAMs (157.5 ± 18.0 µm) (n = 10). An 
example of increased imaging depth in fibrin BAMs is shown in Fig. 5A as 
increased depth along the z axis. Note that the imaging depth for the fibrin BAMs 
included the full thickness of the BAM. 
 Immunohistochemical staining for tropomyosin, a marker for myofibers, 
was performed on fixed tissue prior to clearing. This staining clearly labeled 
myofibers red (Alexa 568) and myofiber alignment could be assessed to a depth 
Page 16 of 32






























































For Peer Review Only
 17
of 142.3 ± 23.4 µm (n = 30) (Fig. 5B). Red fluorescence from labeled myofibers 
was undetectable after clearing with ScaleA2. Therefore, immunohistochemical 
staining for tropomyosin was performed again after clearing to test whether the 
antibody could still recognize tropomyosin. Unfortunately, immunohistochemical 
staining after clearing with ScaleA2 was unsuccessful.  
 By contrast to clearing with ScaleA2, clearing in ClearT2 preserved 
tropomyosin immunohistochemical staining in fibrin BAMs (Fig. 5B). Despite a 
weaker signal, clearing of fibrin BAMs using Clear
T2
 resulted in significantly 
increased visualization of immunohistochemically stained myofibers to a depth of 
166.0 ± 19.1 µm (n = 10) compared to uncleared tissue (p < 0.05). 3DISCO clearing 
of fibrin BAMs also preserved immunohistochemical staining and permitted 
visualization of the stained myofibers to a depth of 293.0 ± 34.4 µm (n = 10) (Fig. 
5B), a significant increase compared to uncleared tissue (p < 0.001).  
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Discussion 
Three-dimensional visualization of tissues has improved dramatically owing to 
novel microscopy techniques and improved tissue processing and staining 
methods. The depth of visualization of tissue remains limited due to scattering 
and refraction of light as it penetrates the tissue. Two-photon microscopy based 
on a femtosecond laser enables deeper photon penetration and less cytotoxicity, 
but with lower resolution. 
Optical clearing is an emerging technology for reducing light scattering by 
increasing tissue transparency, which increases depth of imaging. Great 
improvement in clearing thick tissue has been demonstrated for brain (Chung et 
al. 2013, Hama et al. 2011, Kuwajima et al. 2013). ScaleA2 has been used to study 
the vascular niche for neural stem cells (Hama et al. 2011), whereas Clear
T2
 has 
been used to improve imaging of axonal projections (Kuwajima et al. 2013). 
Tissues such as brain, spinal cord, immunity organs and tumors were cleared 
efficiently using 3DISCO (Ertürk et al. 2012). Because these clearing methods 
might be useful for other tissues, we investigated their potential for muscle 
research and muscle tissue engineering where 3D imaging is important for 
investigating cell behavior including survival, proliferation, migration and 
differentiation.  
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 Without clearing, confocal imaging of endogenous GFP in native mouse 
muscle could be detected 162.3 ± 29.5 µm deep in the tissue; however, good 
resolution was obtained only to 74.5 ± 22.2 µm, the thickness of 1−2 myofibers. 
Clearing the muscle with Clear
T2
 did not significantly increase the depth of 
visualization. By contrast, after ScaleA2 clearing, the GFP signal could be detected 
to 313.3 ± 41.4 µm with good resolution to 145.8 ± 56.1 µm deep, an increase in 
depth of 50%. Compared to uncleared tissue, 3DISCO clearing produced a 250% 
increase in depth of GFP visualization (400.8 ± 30.6 µm) with a 500% increase 
(372.1 ± 46.2 µm) in depth of optimal resolution. Macroscopic observations 
indicated that Clear
T2
 did not improve tissue transparency, whereas ScaleA2 
clearly improved transparency and 3DISCO produced a glass-like consistency.  
Neither ScaleA2 nor ClearT2 significantly altered the size of the muscle 
specimens, while 3DISCO caused significant shrinkage of the tissue. To the 
contrary, Kuwajima et al. (2013) reported that ScaleA2 clearing of brain caused a 
1.25-fold linear expansion. Differences in shrinkage, as well as differences in 
efficiency of the clearing procedures likely can be attributed to the different 
composition of brain tissue compared to skeletal muscle.  
 Mature skeletal muscle differs from bio-artificial muscle in vascularization, 
innervation and composition of extracellular matrix. The composition of the 
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extracellular matrix affects tissue opacity and therefore also the result of optical 
clearing. We created BAMs with a fibrin extracellular matrix and a type I collagen 
extracellular matrix. For BAMs with a collagen extracellular matrix, clearing with 
ScaleA2 or ClearT2 did not increase the transparency of the tissue. By contrast, 
3DISCO produced maximal transparency for the collagen and fibrin BAMs.  
ScaleA2 significantly increased the depth of visualization of endogenous 
GFP in fibrin BAMs from 180.8 ± 18.4 µm (uncleared) to 290.0 ± 24.4 µm, a 60% 
increase. ScaleA2 caused disruption of the fluorescent signal of 
immunohistochemical staining for tropomyosin, however, and the tissue could 
not be re-stained after clearing. Our observations differ from those of Hama et al. 
(2011), who reported at least some successful immunohistochemical staining in 
mouse brain after ScaleA2 clearing. Consistent with our observations, however, 
Kuwajima et al. (2013) reported that ScaleA2 and BABB disrupt the fluorescent 
signal of conventional lipophilic carbocyanine dyes and certain fluorescent 
tracers. Another disadvantage of ScaleA2 compared to ClearT2 and 3DISCO is the 
time required for clearing: 2 weeks versus < 1 day. 
Clear
T2
 treatment did not increase the depth of visualization of endogenous 
GFP in fibrin BAMs and it reduced the endogenous GFP signal. On the other hand, 
Clear
T2
 was compatible with immunohistochemical staining and enabled 17% 
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deeper imaging of the stained myofibers. Our observation that Clear
T2 
treatment 
increased the depth of visualization of immunohistochemical staining is consistent 
with a report for brain tissue (Kuwajima et al. 2013). 
3DISCO clearing not only produced a 62% increase in the depth of 
visualization of endogenous GFP signals, it also preserved immunohistochemical 
staining and caused a two-fold increase in depth of visualization of stained 
myofibers. Because 3DISCO treatment hardens tissue, the original cylindrical 
shape of the bio-artificial muscles is retained, by contrast to Clear
T2
 and ScaleA2, 
which caused the tissue to soften and flatten when placed on a glass slide. We 
demonstrated that bio-artificial muscle can be visualized throughout its diameter 
after 3DISCO clearing (Fig. 5A, B).  
We found that for both native and tissue engineered muscle, Clear
T2
 
treatment does not improve depth of visualization of endogenous GFP. Although 
Clear
T2
 preserves immunohistochemical staining, it cannot be recommended as a 
clearing agent for native and engineered muscle tissue. ScaleA2 is a good clearing 
agent that preserves endogenous GFP and permits deep imaging of GFP. The 
disadvantages of ScaleA2 include the requirement for a long incubation time (2 
weeks) and its incompatibility with immunohistochemical staining. For both 
native and tissue engineered muscle, we demonstrated that 3DISCO treatment is 
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rapid and permits deep imaging of both endogenous GFP and 
immunohistochemical staining. We suggest that 3DISCO is the clearing method of 
choice for native and tissue engineered muscle. 
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Fig. 1. Transparency of mouse skeletal muscle before and after clearing with 
Clear
T2
, ScaleA2 and 3DISCO. Scale bar = 1 cm. 
Fig. 2. Depth of GFP detection in mouse GFP-expressing skeletal muscle tissue. 
Confocal imaging of mouse GFP-expressing skeletal muscle tissue before and after 
clearing with Clear
T2
, ScaleA2 and 3DISCO. Three-dimensional reconstructions of 
image stacks. Note the differences of imaging depth on the z axis. 
Fig. 3. Quantitative representation of GFP imaging depth in mouse GFP-expressing 
skeletal muscle tissue and fibrin BAMs containing GFP-expressing HUVECs. A) Box 
plot representing depth of GFP signal in uncleared, Clear
T2
, ScaleA2 and 3DISCO 
cleared mouse GFP-expressing skeletal muscle tissue. B) Box plot representing 
depth of GFP signal in uncleared, Clear
T2
, ScaleA2 and 3DISCO cleared fibrin BAMs 
containing 3 x 10
5
 GFP-expressing HUVECs and 7 x 10
5
 myoblasts. **p < 0.01, ***p 
< 0.001. 
Fig. 4. Transparency of bio-artificial muscle before and after clearing. First 
column) BAMs constructed in a collagen ECM without clearing and after clearing 
with Clear
T2
, ScaleA2 and 3DISCO. Second column) BAMs constructed in a fibrin 
ECM, without clearing and cleared in Clear
T2
, ScaleA2 and 3DISCO. Scale bar = 1 
cm. 
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Fig. 5. Three-dimensional reconstruction of confocal images of fibrin bio-artificial 
muscles. A) GFP signals in bio-artificial muscles containing GFP-expressing HUVECs 
are shown before and after clearing with Clear
T2
, ScaleA2 and 3DISCO. B) 
Immunohistochemical staining of tropomyosin (muscle-specific marker; red) and 
endogenous GFP fluorescence (green) in fibrin BAMs containing GFP-HUVECs and 
myoblasts before and after clearing with Clear
T2
 and 3DISCO.  
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